Write in a clean editor, then format for Pharmacoepidemiology in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Pharmacoepidemiology is a peer-reviewed journal published by MDPI, covering Pharmacovigilance and Adverse Drug Reactions, Statistical Methods in Clinical Trials, Pharmaceutical Practices and Patient Outcomes. Over its lifetime it has published 351 papers, which have received 2,955 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Pharmacoepidemiology 2023, 12, 45–58.
Formats any DOI in Pharmacoepidemiology style. No sign-up. |
| Publishes research in | Pharmacovigilance and Adverse Drug Reactions Statistical Methods in Clinical Trials Pharmaceutical Practices and Patient Outcomes Health Systems, Economic Evaluations, Quality of Life Pharmaceutical studies and practices |
| ISSN | 2813-0618 |
| Citation impact (2-yr) | 1.62 |
| h-index | 31 |
| i10-index | 72 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of California, Irvine |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Irrational and inappropriate prescribing of antibiotics is a major problem that can lead to the development of antimicrobial resistance (AMR). In Zambia, there is insufficient information on the prescribing patterns of antibiotics according to the World Health Organization (WHO) AWaRe classification. Therefore, this study assessed the prescribing patterns of antibiotics using the AWaRe classification during…
Adverse drug reactions (ADRs) are frequent and represent a significant healthcare burden. ADRs are a potentially avoidable contributor to excess unscheduled hospital admissions, higher morbidity, mortality, and healthcare costs. The objective of this review is to examine the epidemiology of ADRs in older multimorbid adults and to explore strategies for ADR prevention. ADRs in this…
Helicobacter pylori is a class I carcinogen that infects more than 100 million individuals in the United States. Antimicrobial therapy for H. pylori has typically been prescribed empirically rather than based on susceptibility testing. Until recently, therapeutic recommendations have generally ignored the principles of antibiotic stewardship. A combination of a proton pump inhibitor (PPI), amoxicillin,…
The pandemic outbreak of Coronavirus disease 2019 (COVID-19) has drastically changed the picture of global healthcare. With the rapid emergence of novel variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that rendered the currently available therapeutic and diagnostic approaches inefficient in containing the transmission of infection, it becomes important to focus on strategies to break…
Opioid use disorder (OUD) is a chronic disease requiring long-term treatment and is associated with opioid overdose and increased risk of mortality. However, existing randomized clinical trials focused on short-term treatment engagement and detoxification rather than overdose or mortality risk due to limited follow-up time and ethical considerations. We used a hypothetical trial framework to…
